4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000182
Chairperson & CEO sold 1,960 shares at an average $597.76 ($1,171,609)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-05 | Sale : show line 1 in the form 10b5-1 | −200 | $593.14 | $118,628 | 326,203 | I |
| 2026-11-05 | Sale : show line 2 in the form 10b5-1 | −280 | $594.51 | $166,464 | 325,923 | I |
| 2026-11-05 | Sale : show line 3 in the form 10b5-1 | −120 | $595.43 | $71,452 | 325,803 | I |
| 2026-11-05 | Sale : show line 4 in the form 10b5-1 | −306 | $596.71 | $182,593 | 325,497 | I |
| 2026-11-05 | Sale : show line 5 in the form 10b5-1 | −237 | $597.74 | $141,665 | 325,260 | I |
| 2026-11-05 | Sale : show line 6 in the form 10b5-1 | −167 | $598.74 | $99,989 | 325,093 | I |
| 2026-11-05 | Sale : show line 7 in the form 10b5-1 | −10 | $599.80 | $5,998 | 325,083 | I |
| 2026-11-05 | Sale : show line 8 in the form 10b5-1 | −560 | $601.11 | $336,620 | 324,523 | I |
| 2026-11-05 | Sale : show line 9 in the form 10b5-1 | −80 | $602.49 | $48,199 | 324,443 | I |
| Open-market sales · 1,960 sh · avg $597.76 · $1,171,609 | ||||||
Loading xslF345X06/primarydocument.xml…